Insulet Corp. (PODD) Misses Q1 EPS by 1c, Offers Q2, FY Rev. Guiance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Insulet Reports First Quarter 2015 Financial Results
April 30, 2015 4:01 PM EDTBILLERICA, MA -- (Marketwired) -- 04/30/15 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced financial results for the three months ended March 31, 2015.
First Quarter Highlights and Recent Developments:
First quarter financial results: U.S. OmniPod revenue in-line with Company's expectations. Drug Delivery and International shipments planned for the first quarter now expected to be realized during remainder of 2015. Strengthened senior leadership team with appointment of highly-experienced Chief Financial Officer. Previously announced: First... More